Search Results - Ofer Rotem

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancer by Yosef Landman, Oded Jacobi, Noga Kurman, Orly Yariv, Idit Peretz, Ofer Rotem, Elizabeth Dudnik, Alona Zer, Aaron M. Allen

    Published in OncoImmunology (2021-01-01)
    Get full text
    Article


  2. 2

    Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non‐small cell lung cancer: A large real‐world cohort and review of the l... by Itamar Averbuch, Roi Tschernichovsky, Oded Icht, Daniel A. Goldstein, Raz Mutai, Elizabeth Dudnik, Ofer Rotem, Nir Peled, Aaron M. Allen, Smadar Laufer‐Geva, Yael Goldberg, Alona Zer

    Published in Thoracic Cancer (2023-06-01)
    Get full text
    Article


  3. 3

    Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung by Samuel Kareff, Jair Bar, Amir Onn, Alona Zer, Chul Kim, Stephen V Liu, Elizabeth Dudnik, Mor Moskovitz, Anastasiya Lobachov, Teodor Gottfried, Damien Urban, Ofer Rotem, Mira Wollner

    Published in Journal for ImmunoTherapy of Cancer (2021-02-01)
    Get full text
    Article


  4. 4

    Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy by Ofer Rotem, Alona Zer, Lilach Yosef, Einat Beery, Hadar Goldvaser, Anna Gutkin, Ron Levin, Elizabeth Dudnik, Tamar Berger, Meora Feinmesser, Adva Levy-Barda, Meir Lahav, Pia Raanani, Orit Uziel

    Published in Biomedicines (2023-06-01)
    Get full text
    Article


  5. 5

    Seeing the Trees From the Forest: Challenges in Subgroup Analysis-Based Guidelines in Oncology by Ofer Rotem, Karyn Revital Geiger, Karyn Revital Geiger, Ekaterina Hanovich, Mor Moskovitz, Noga Kurman, Daniel Reinhorn, Daniel Reinhorn, Idit Peretz, Rinat Yerushalmi, Rinat Yerushalmi, Salomon M. Stemmer, Salomon M. Stemmer

    Published in Oncology Reviews (2024-05-01)
    Get full text
    Article


  6. 6

    Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world da... by Elizabeth Dudnik, Mor Moskovitz, Yakir Rottenberg, Anastasiya Lobachov, Rinat Mandelboim, Tzippy Shochat, Damien Urban, Mira Wollner, Hovav Nechushtan, Ofer Rotem, Alona Zer, Sameh Daher, Jair Bar, On behalf of the Israel Lung Cancer Group

    Published in OncoImmunology (2021-01-01)
    Get full text
    Article


  7. 7

    Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study by Ofer Rotem, Idit Peretz, Michelle Leviov, Iryna Kuchuk, Amit Itay, Margarita Tokar, Shani Paluch-Shimon, Ofra Maimon, Rinat Yerushalmi, Karen Drumea, Ella Evron, Amir Sonnenblick, Einav Gal-Yam, Hadar Goldvaser, Yosef Samih, Rotem Merose, Avital Bareket-Samish, Lior Soussan-Gutman, Salomon M. Stemmer

    Published in npj Breast Cancer (2023-06-01)
    Get full text
    Article


Search Tools: